Apollomics Dividends
| APLM Stock | 7.16 1.19 14.25% |
As of the 11th of December 2024, Dividend Paid And Capex Coverage Ratio is likely to grow to -6,841. Apollomics' past performance could be the main factor of why investors trade Apollomics Class A stock today. Investors should clearly understand every aspect of the Apollomics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Apollomics' dividend schedule and payout information. Apollomics Class A dividends can also provide a clue to the current valuation of Apollomics.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | -7.2 K | -6.8 K |
Apollomics Quarterly Total Cash From Financing Activities |
|
Apollomics |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Apollomics must own a stock before its ex-dividend date to receive its next dividend.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apollomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.023 | Quarterly Revenue Growth 2.623 | Return On Assets (0.63) | Return On Equity (1.49) |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apollomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Apollomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apollomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.